ARIE Capital Technology EIS Fund 3 investee profile

by | Sep 30, 2020

Share this article

Producing chemical-free, clean, naturally grown food, and reducing food waste is critical.

UK food shrinkage is at £11 billion per year. In the United States, 40% of food gets thrown away every year, which amounts to $162 billion in waste annually, according to the Natural Resources Defense Council.

Since 2014, Vitabeam has developed, field-tested and professionally validated patented devices that simultaneously supercharge the growth and yield of produce and kill pathogens (mould and bacteria) with a natural, chemical-free patented energy formula.

 
 

The implementation of this technology will benefit 6 global markets, with positive ROI and health and safety benefits to perishable foods we depend on or enjoy; fruits, vegetables, meat, fish, seafood and flowers.

Vitabeam’s patented VQe (Vitabeam Quantum energy) is the proprietary “cocktail” of wavelengths of light found in the natural sunlight spectrum; this is used in all Vitabeam products.

Vitabeam’s MaxStrip uses VQe to extend the shelf-life of fresh produce without the need for any chemicals. As a result, the MaxStrip can be used safely and easily by growers and retailers, as well as in the home, to save energy and reduce food waste.

 
 

Vitabeam’s Steril Max delivers high-powered disinfection and sanitising capabilities to growers in their pre-packaging process, as well as to healthcare across all care environments. In independent trials at a top US lab, Steril Max killed 99.9999% of harmful bacteria commonly present on foods and in hospitals.

Steril Max is expected to be highly effective at killing viruses, including COVID-19.

Vitabeam supercharges growth by increasing photosynthesis, resulting in an increase of carbon dioxide uptake and oxygen production, as well as increased nutrient uptake, for a greener planet.

 
 

Key highlights

  • £3m EIS equity raise (series A)
  • Opportunity to invest in a green, high-growth potential, Agri/Bio tech under attractive EIS conditions
  • Vitabeam is focused on 6 global markets, with commercially ready devices for food supply from farm to fork, medical cannabis and healthcare
  • Professionally field-tested to prove increased yield and potency
  • Commercial sales completed in the US, Canada and Hawaii. Global sales rollout to occur with funding
  • Strong ROI benefits to all customers, e.g. within 3 to 9 months for growers and 6 to 9 months for retailers, with a product warranty of 5 years
  • Exit opportunities for maximum PE valuation IPO / trade sales to multiple large sector companies, offering multiple potential routes for returns
  • Awarded two UK Government grants in horticulture, with many more options available for other sector awards
  • Strong pipeline revenue committed for 2021; included in new build projects standards, while retrofit is also viable, presenting huge commercial opportunities
  • Proven, patented, safe, world-first science

Share this article

Related articles

IFAM 127 | Not if, but when | April 2024

IFAM 127 | Not if, but when | April 2024

Not if, but when… Spring finally seems to have arrived! Since our last edition, we have had the Spring Budget and the Bank of England (BoE) rate announcement to name but a few important landmarks. This has kept us, like all of you I am sure, quite busy over the last...

Sign up to the IFA Magazine Newsletter

Trending articles

IFA Talk logo

IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.

IFA Talk Podcast - listen to the latest episode

x